Published in Biophys J on September 07, 2011
Selection of DNA binding sites by regulatory proteins. Statistical-mechanical theory and application to operators and promoters. J Mol Biol (1987) 17.53
Crystal structure of the lactose operon repressor and its complexes with DNA and inducer. Science (1996) 9.34
Diversity and complexity in DNA recognition by transcription factors. Science (2009) 9.07
How do site-specific DNA-binding proteins find their targets? Nucleic Acids Res (2004) 6.17
Structure and flexibility adaptation in nonspecific and specific protein-DNA complexes. Science (2004) 4.92
Nucleotides of transcription factor binding sites exert interdependent effects on the binding affinities of transcription factors. Nucleic Acids Res (2002) 4.83
Origins of specificity in protein-DNA recognition. Annu Rev Biochem (2010) 4.43
Kinetics of protein-DNA interaction: facilitated target location in sequence-dependent potential. Biophys J (2004) 3.93
Analysis of the sequence-specific interactions between Cro repressor and operator DNA by systematic base substitution experiments. Proc Natl Acad Sci U S A (1989) 2.76
Nonspecific DNA binding of genome-regulating proteins as a biological control mechanism: measurement of DNA-bound Escherichia coli lac repressor in vivo. Proc Natl Acad Sci U S A (1977) 2.70
Lambda repressor recognizes the approximately 2-fold symmetric half-operator sequences asymmetrically. Proc Natl Acad Sci U S A (1989) 2.61
Octamerization of lambda CI repressor is needed for effective repression of P(RM) and efficient switching from lysogeny. Genes Dev (2001) 2.53
One- and three-dimensional pathways for proteins to reach specific DNA sites. EMBO J (2000) 2.16
Quantitative high-throughput analysis of transcription factor binding specificities. Nucleic Acids Res (2004) 1.87
Crystal structure of the lambda repressor and a model for pairwise cooperative operator binding. Nature (2008) 1.35
In vivo non-specific binding of lambda CI and Cro repressors is significant. FEBS Lett (2004) 1.23
Cytoplasmic RNA Polymerase in Escherichia coli. J Bacteriol (2001) 1.19
Simulation of the kinetics of a sphere attached to a fluctuating polymer: Implications for target search by DNA-binding proteins. Phys Rev E Stat Nonlin Soft Matter Phys (2004) 0.77
Specific inhibition of p300-HAT alters global gene expression and represses HIV replication. Chem Biol (2007) 2.15
X-ray studies of crystalline complexes involving amino acids and peptides. XLIII. Adipic acid complexes of L- and DL-lysine. Acta Crystallogr C (2006) 1.43
X-ray studies of crystalline complexes involving amino acids and peptides. XLIV. Invariant features of supramolecular association and chiral effects in the complexes of arginine and lysine with tartaric acid. Acta Crystallogr B (2007) 1.38
Molecular basis for H3K36me3 recognition by the Tudor domain of PHF1. Nat Struct Mol Biol (2012) 1.27
Structural plasticity and enzyme action: crystal structures of mycobacterium tuberculosis peptidyl-tRNA hydrolase. J Mol Biol (2007) 1.24
Natural products: promising resources for cancer drug discovery. Anticancer Agents Med Chem (2012) 1.23
Molecular basis of phosphatidylinositol 4-phosphate and ARF1 GTPase recognition by the FAPP1 pleckstrin homology (PH) domain. J Biol Chem (2011) 1.21
Histone deacetylase regulation of ATM-mediated DNA damage signaling. Mol Cancer Ther (2013) 1.15
The MBT repeats of L3MBTL1 link SET8-mediated p53 methylation at lysine 382 to target gene repression. J Biol Chem (2010) 1.13
The prevalence, distribution, and clinical outcomes of electrocardiographic repolarization patterns in male athletes of African/Afro-Caribbean origin. Eur Heart J (2011) 1.05
Prevalence and risk factors of asthma and wheeze in school-going children in Lucknow, North India. Indian Pediatr (2004) 1.05
Risk and resilience for psychological distress amongst unaccompanied asylum seeking adolescents. J Child Psychol Psychiatry (2008) 1.02
Differential recognition of phosphorylated transactivation domains of p53 by different p300 domains. J Mol Biol (2007) 1.01
Kinetics of transcription initiation at lacP1. Multiple roles of cyclic AMP receptor protein. J Biol Chem (2003) 0.97
Metabolic and morphological differences between rapidly proliferating cancerous and normal breast epithelial cells. Biotechnol Prog (2008) 0.96
SMAR1 forms a ternary complex with p53-MDM2 and negatively regulates p53-mediated transcription. J Mol Biol (2009) 0.96
Simvastatin and tempol protect against endothelial dysfunction and renal injury in a model of obesity and hypertension. Am J Physiol Renal Physiol (2009) 0.95
Molecular mechanism of MLL PHD3 and RNA recognition by the Cyp33 RRM domain. J Mol Biol (2010) 0.94
Aib-based peptide backbone as scaffolds for helical peptide mimics. J Pept Res (2002) 0.94
Structural determinant of human La protein critical for internal initiation of translation of hepatitis C virus RNA. J Virol (2008) 0.93
DnaK-sigma 32 interaction is temperature-dependent. Implication for the mechanism of heat shock response. J Biol Chem (2002) 0.91
SMAR1 regulates free radical stress through modulation of AKR1a4 enzyme activity. Int J Biochem Cell Biol (2010) 0.89
Low prevalence of risk markers in cases of sudden death due to Brugada syndrome relevance to risk stratification in Brugada syndrome. J Am Coll Cardiol (2011) 0.89
Slow solvation dynamics at the active site of an enzyme: implications for catalysis. Biochemistry (2005) 0.88
Cellular and molecular mechanisms of cigarette smoke-induced lung damage and prevention by vitamin C. J Inflamm (Lond) (2008) 0.86
Role of C-terminal residues in oligomerization and stability of lambda CII: implications for lysis-lysogeny decision of the phage. J Mol Biol (2005) 0.86
Effect of phosphorylation on the structure and fold of transactivation domain of p53. J Biol Chem (2002) 0.85
The zinc-binding site of a class I aminoacyl-tRNA synthetase is a SWIM domain that modulates amino acid binding via the tRNA acceptor arm. Eur J Biochem (2004) 0.85
Specific small-molecule activator of Aurora kinase A induces autophosphorylation in a cell-free system. J Med Chem (2008) 0.85
Combined histone deacetylase inhibition and tamoxifen induces apoptosis in tamoxifen-resistant breast cancer models, by reversing Bcl-2 overexpression. Breast Cancer Res (2015) 0.84
Glutamate counteracts the denaturing effect of urea through its effect on the denatured state. J Biol Chem (2003) 0.83
P-protein of Chandipura virus is an N-protein-specific chaperone that acts at the nucleation stage. Biochemistry (2004) 0.83
Efficacy of histone deacetylase and estrogen receptor inhibition in breast cancer cells due to concerted down regulation of Akt. PLoS One (2013) 0.81
Small cationic protein from a marine turtle has beta-defensin-like fold and antibacterial and antiviral activity. Proteins (2006) 0.81
Monomer and dimer of Chandipura virus unphosphorylated P-protein binds leader RNA differently: implications for viral RNA synthesis. J Mol Biol (2004) 0.81
Binding of the histone chaperone ASF1 to the CBP bromodomain promotes histone acetylation. Proc Natl Acad Sci U S A (2014) 0.81
A functional loop spanning distant domains of glutaminyl-tRNA synthetase also stabilizes a molten globule state. Biochemistry (2012) 0.81
A chimaeric glutamyl:glutaminyl-tRNA synthetase: implications for evolution. Biochem J (2009) 0.81
The role of the catalytic domain of E. coli GluRS in tRNAGln discrimination. FEBS Lett (2009) 0.81
Specific sequence of a Beta turn in human la protein may contribute to species specificity of hepatitis C virus. J Virol (2014) 0.80
Solvation dynamics of a protein in the pre molten globule state. J Phys Chem B (2006) 0.80
Antagonists of Hsp16.3, a low-molecular-weight mycobacterial chaperone and virulence factor, derived from phage-displayed peptide libraries. Appl Environ Microbiol (2005) 0.80
Blood pressure oscillations during tilt testing as a predictive marker of vasovagal syncope. Europace (2009) 0.80
Characterization of early repolarization during ajmaline provocation and exercise tolerance testing. Heart Rhythm (2012) 0.79
Peptide-protein interactions suggest that acetylation of lysines 381 and 382 of p53 is important for positive coactivator 4-p53 interaction. J Biol Chem (2011) 0.79
Cloning, expression, purification, crystallization and preliminary X-ray analysis of peptidyl-tRNA hydrolase from Mycobacterium tuberculosis. Acta Crystallogr Sect F Struct Biol Cryst Commun (2006) 0.79
Half-of-the-sites reactivity of F235C lambda-repressor: implications for the structure of the whole repressor. Protein Eng (2002) 0.79
Hypertrophic cardiomyopathy and ultra-endurance running - two incompatible entities? J Cardiovasc Magn Reson (2011) 0.79
Disorder-order transition of lambda CII promoted by low concentrations of guanidine hydrochloride suggests a stable core and a flexible C-terminus. Eur J Biochem (2003) 0.79
A synthetic peptide mimic of λ-Cro shows sequence-specific binding in vitro and in vivo. ACS Chem Biol (2012) 0.78
Human placental extract mediated inhibition of proteinase K: implications of heparin and glycoproteins in wound physiology. J Cell Physiol (2014) 0.77
Structural features of human histone acetyltransferase p300 and its complex with p53. FEBS Lett (2012) 0.77
A cyclic peptide mimic of an RNA recognition motif of human La protein is a potent inhibitor of hepatitis C virus. Antiviral Res (2013) 0.77
Simultaneous inhibition of key growth pathways in melanoma cells and tumor regression by a designed bidentate constrained helical peptide. Biopolymers (2014) 0.76
Recognition of different DNA sequences by a DNA-binding protein alters protein dynamics differentially. FEBS Lett (2012) 0.76
Conformational adaptation in the E. coli sigma 32 protein in response to heat shock. J Phys Chem B (2014) 0.76
Indirect read-out of the promoter DNA by RNA polymerase in the closed complex. Nucleic Acids Res (2012) 0.75
Solvation change and ion release during aminoacylation by aminoacyl-tRNA synthetases. Nucleic Acids Res (2003) 0.75
A genetic network that balances two outcomes utilizes asymmetric recognition of operator sites. Biophys J (2012) 0.75
Switching DNA-binding specificity by unnatural amino acid substitution. Nucleic Acids Res (2005) 0.75
A peptide targeted against phosphoprotein and leader RNA interaction inhibits growth of Chandipura virus -- an emerging rhabdovirus. Antiviral Res (2013) 0.75
Ultrafast differential flexibility of Cro-protein binding domains of two operator DNAs with different sequences. Phys Chem Chem Phys (2016) 0.75
Determination of aliphatic amines by gas chromatography-mass spectrometry after in-syringe derivatization with pentafluorobenzoyl chloride. J Chromatogr A (2011) 0.75
Alternative sigma factors in the free state are equilibrium mixtures of open and compact conformations. Biochemistry (2010) 0.75
International symposium on challenges in chemical biology: toward the formation of Chemical Biology Society of India. ACS Chem Biol (2013) 0.75
Removal of lead from aqueous solution by hybrid precursor prepared by rice hull. J Hazard Mater (2008) 0.75
Aortic valve replacement for Libman-Sacks endocarditis. Ann Thorac Surg (2009) 0.75
X-ray studies on crystalline complexes involving amino acids and peptides. XLI. Commonalities in aggregation and conformation revealed by the crystal structures of the pimelic acid complexes of L-arginine and DL-lysine. Acta Crystallogr B (2003) 0.75
Optimal design of metabolic flux analysis experiments for anchorage-dependent mammalian cells using a cellular automaton model. Biotechnol Bioeng (2007) 0.75
Ligand specificity and ligand-induced conformational change in gal repressor. Proteins (2002) 0.75
Conformational selection underpins recognition of multiple DNA sequences by proteins and consequent functional actions. Phys Chem Chem Phys (2016) 0.75
Chemical biology research in India. ACS Chem Biol (2011) 0.75